Advanced therapies—including biologics, radiopharmaceuticals, cell & gene therapies, and antibody-drug conjugates (ADCs)—are reshaping modern medicine. But their complexity also introduces unique manufacturing, compliance, and safety challenges. With evolving regulatory frameworks, sensitive materials, and high-containment requirements, speed to market and patient safety hinge on robust, compliant operations.
Pinnaql delivers expert, cross-functional support for advanced therapeutic development. Our teams understand the stringent demands of these emerging modalities and offer lifecycle-aligned solutions—from lab design and containment strategy to GMP manufacturing and aseptic fill-finish. We help clients bring therapies to life—safely, efficiently, and in full regulatory compliance.
Pinnaql enables biotech, CGT, ADC, and radiopharma innovators to move faster—without compromising quality or compliance
Specialized SOPs, validation, and cleanroom support for biologics, radioactive drugs, and gene therapies.
High-containment systems, aseptic processing, and isolator-based fill-finish for potent and hazardous products.
Engineers, scientists, and quality experts collaborate across modalities and lifecycle stages.
Validation, CQV, and risk mitigation strategies tailored to your regulatory pathway.
From early-stage development through commercial manufacturing.
101 Lindenwood Drive, Suite 225, Malvern, PA 19355
9800 Crosspoint Blvd, Suite 200, Indianapolis, IN 46256